Highlights
- RAD would present at the NWR Virtual Healthcare Conference.
- Vittorio Puppo, chief operating officer of RAD would deliver the presentation.
Radiopharm Theranostics Limited (ASX: RAD) informed that it will present at the NWR Virtual Healthcare Conference. The event is scheduled to happen on 20 – 21 March 2024. The presentation will be delivered by the chief operating officer of RAD, Vittorio Puppo on 21 March 2024 at 9:00 AM AEDT.
About Radiopharm Theranostics
RAD is a clinical stage radiotherapeutics company, focused on creating a platform of innovative radiopharmaceutical products for therapeutic and diagnostic applications in areas of high unmet medical needs.
The company manages a pipeline of different platform technologies covering small molecules, peptides and monoclonal antibodies. The technologies are being developed for use in cancer, clinical and pre-clinical stages of development from some of the leading institutes and universities. The pipeline of RAD have unique potential of being best in class or first to market.
The company is presently advancing RAD 301, RAD 302, RAD 101, RAD 204, RAD 202, RV01 trials.
RAD shares traded at AU$0.06 apiece at the time of writing o 19 March 2024.